Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury

Experimental Eye Research

Volumn 85, Issue 5, 2007, Pages 608-616

  Cheung, Alvin K H ^a   Lo, Amy C Y ^a   So, Kwok Fai ^a   Chung, Stephen S M ^a   Chung, Sookja K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

edema; ischemia; M ller cells; neuronal apoptosis; retinal ganglion cell; sorbitol dehydrogenase

Indexed keywords

3 NITROTYROSINE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; CP 470711; FIDARESTAT; IDITOL DEHYDROGENASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLYOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EDEMA; ENZYME INHIBITION; GENE DELETION; GENE MUTATION; MOUSE; NERVE CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; RETINA ARTERY OCCLUSION; RETINA ISCHEMIA; SUTURE; WILD TYPE;

ALDEHYDE REDUCTASE; ANIMALS; APOPTOSIS; GENE DELETION; GLUTAMIC ACID; IMIDAZOLIDINES; L-IDITOL 2-DEHYDROGENASE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEUROGLIA; OXIDATIVE STRESS; PAPILLEDEMA; PYRIMIDINES; REPERFUSION INJURY; RETINAL DISEASES; RETINAL GANGLION CELLS;

EID: 35549010197     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.07.013     Document Type: Article

References (43)

1. Asnaghi V., Gerhardinger C., Hoehn T., Adeboje A., and Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52 (2003) 506-511
2. Aydemir O., Celebi S., Yilmaz T., Yekeler H., and Kukner A.S. Protective effects of vitamin E forms (alpha-tocopherol, gamma-tocopherol and d-alpha-tocopherol polyethylene glycol 1000 succinate) on retinal edema during ischemia-reperfusion injury in the guinea pig retina. Int. Ophthalmol. 25 (2004) 283-289
3. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1620-1624
4. Block F., Grommes C., Kosinski C., Schmidt W., and Schwarz M. Retinal ischemia induced by the intraluminal suture method in rats. Neurosci. Lett. 232 (1997) 45-48
5. Block F., and Schwarz M. Effects of antioxidants on ischemic retinal dysfunction. Exp. Eye Res. 64 (1997) 559-564
6. Block F., and Schwarz M. The b-wave of the electroretinogram as an index of retinal ischemia. Gen. Pharmacol. 30 (1998) 281-287
7. Block F., Schwarz M., and Sontag K.H. Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography. Neurosci. Lett. 144 (1992) 124-126
8. Bonne C., Muller A., and Villain M. Free radicals in retinal ischemia. Gen. Pharmacol. 30 (1998) 275-280
9. Bucciarelli L.G., Kaneko M., Ananthakrishnan R., Harja E., Lee L.K., Hwang Y.C., Lerner S., Bakr S., Li Q., Lu Y., Song F., Qu W., Gomez T., Zou Y.S., Yan S.F., Schmidt A.M., and Ramasamy R. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury. Circulation 113 (2006) 1226-1234
10. Buchi E.R. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp. Eye Res. 55 (1992) 605-613
11. Cheung A.K., Fung M.K., Lo A.C., Lam T.T., So K.F., Chung S.S., and Chung S.K. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54 (2005) 3119-3125
12. Chu-Moyer M.Y., Ballinger W.E., Beebe D.A., Berger R., Coutcher J.B., Day W.W., Li J., Mylari B.L., Oates P.J., and Weekly R.M. Orally-effective, long-acting sorbitol dehydrogenase inhibitors: synthesis, structure-activity relationships, and in vivo evaluations of novel heterocycle-substituted piperazino-pyrimidines. J. Med. Chem. 45 (2002) 511-528
13. Chu-Moyer M.Y., Ballinger W.E., Beebe D.A., Coutcher J.B., Day W.W., Li J., Oates P.J., and Weekly R.M. Sar and species/stereo-selective metabolism of the sorbitol dehydrogenase inhibitor, cp-470,711. Bioorg. Med. Chem. Lett. 12 (2002) 1477-1480
14. Chung S.S., and Chung S.K. Aldose reductase in diabetic microvascular complications. Curr. Drug Targets 6 (2005) 475-486
15. Chung S.S., Ho E.C., Lam K.S., and Chung S.K. Contribution of polyol pathway to diabetes-induced oxidative stress. J. Am. Soc. Nephrol. 14 (2003) S233-S236
16. Da T., and Verkman A.S. Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia. Invest. Ophthalmol. Vis. Sci. 45 (2004) 4477-4483
17. Davis M.D. Diabetic retinopathy. A clinical overview. Diabetes Care 15 (1992) 1844-1874
18. Erdelyi K., Bakondi E., Gergely P., Szabo C., and Virag L. Pathophysiologic role of oxidative stress-induced poly(adp-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. Cell Mol. Life Sci. 62 (2005) 751-759
19. Giannoukakis N. Fidarestat. Sanwa kagaku/nc curex/sankyo. Curr. Opin. Investig. Drugs 4 (2003) 1233-1239
20. Hayreh S.S., Kolder H.E., and Weingeist T.A. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 87 (1980) 75-78
21. Hayreh S.S., and Weingeist T.A. Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. Br. J. Ophthalmol. 64 (1980) 818-825
22. Hayreh S.S., Zimmerman M.B., Kimura A., and Sanon A. Central retinal artery occlusion. Retinal survival time. Exp. Eye Res. 78 (2004) 723-736
23. Ho H.T., Chung S.K., Law J.W., Ko B.C., Tam S.C., Brooks H.L., Knepper M.A., and Chung S.S. Aldose reductase-deficient mice develop nephrogenic diabetes insipidus. Mol. Cell Biol. 20 (2000) 5840-5846
24. Hwang Y.C., Bakr S., Ellery C.A., Oates P.J., and Ramasamy R. Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium. FASEB J. 17 (2003) 2331-2333
25. Hwang Y.C., Sato S., Tsai J.Y., Yan S., Bakr S., Zhang H., Oates P.J., and Ramasamy R. Aldose reductase activation is a key component of myocardial response to ischemia. FASEB J. 16 (2002) 243-245
26. Kaneko M., and Ramasamy R. Aldose reductase: a key player in myocardial ischemic injury. Exerc. Sport Sci. Rev. 32 (2004) 19-23
27. Kariserova K., Srivastava S., Hoetker J.D., Awe S.O., Tang X.L., Cai J., and Bhatnagar A. Redox activation of aldose reductase in the ischemic heart. J. Biol. Chem. 281 (2006) 15110-15120
28. Kim I.B., Kim K.Y., Joo C.K., Lee M.Y., Oh S.J., Chung J.W., and Chun M.H. Reaction of muller cells after increased intraocular pressure in the rat retina. Exp. Brain Res. 121 (1998) 419-424
29. Lee F.K., Chung S.K., and Chung S.S. Aberrant mRNA splicing causes sorbitol dehydrogenase deficiency in c57bl/lia mice. Genomics 46 (1997) 86-92
30. Lo A.C., Chen A.Y., Hung V.K., Yaw L.P., Fung M.K., Ho M.C., Tsang M.C., Chung S.S., and Chung S.K. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J. Cereb. Blood Flow Metab. 25 (2005) 998-1011
31. Lo A.C., Cheung A.K., Hung V.K., Yeung C.M., He Q.Y., Chiu J.F., Chung S.S., and Chung S.K. Deletion of aldose reductase leads to protection against cerebral ischemic injury. J. Cereb. Blood Flow Metab (2007)
32. Mekada A., and Hazama F. A rapid, easy technique for defining detailed anatomical orientation in pre-deparaffinized tissue sections. J. Neurosci. Methods 82 (1998) 203-205
33. Ng T.F., Lee F.K., Song Z.T., Calcutt N.A., Lee A.Y., Chung S.S., and Chung S.K. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes 47 (1998) 961-966
34. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
35. Obrosova I.G., Drel V.R., Kumagai A.K., Szabo C., Pacher P., and Stevens M.J. Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabetologia 49 (2006) 2525-2533
36. Petrash J.M. All in the family: aldose reductase and closely related aldo-keto reductases. Cell Mol. Life Sci. 61 (2004) 737-749
37. Ramasamy R. Aldose reductase: a novel target for cardioprotective interventions. Curr. Drug Targets 4 (2003) 625-632
38. Rittner H.L., Hafner V., Klimiuk P.A., Szweda L.I., Goronzy J.J., and Weyand C.M. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J. Clin. Invest. 103 (1999) 1007-1013
39. Shibuki H., Katai N., Yodoi J., Uchida K., and Yoshimura N. Lipid peroxidation and peroxynitrite in retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3607-3614
40. Virag L., Szabo E., Gergely P., and Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol. Lett. 140-141 (2003) 113-124
41. Williamson J.R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., Nyengaard J.R., van den Enden M., Kilo C., and Tilton R.G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42 (1993) 801-813
42. Wilson C.A., Berkowitz B.A., Funatsu H., Metrikin D.C., Harrison D.W., Lam M.K., and Sonkin P.L. Blood-retinal barrier breakdown following experimental retinal ischemia and reperfusion. Exp. Eye Res. 61 (1995) 547-557
43. Zheng L., Gong B., Hatala D.A., and Kern T.S. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest. Ophthalmol. Vis. Sci. 48 (2007) 361-367